Core D - Neuropathology Core
Core D - Neuropathology Core
批准号:
8676353
负责人:
MATTHEW P FROSCH
金额:
$22.85万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2019-03-31
关键词:
AddressAdultAgingAlzheimer&aposs DiseaseAnimal ModelAttentionAuthorization documentationAutopsyBeliefBrainClinicalClinical ResearchClinical assessmentsCollaborationsCollectionCommitCommunicationCommunitiesComplementDNADataData Storage and RetrievalDepositionDiagnosisDiagnosticDiseaseDrug or chemical Tissue DistributionEducationEducational ActivitiesEducational process of instructingEnvironmentEpidemiologic StudiesEvaluationEventFamilyFocus GroupsFreezingFundingGoalsHealth ProfessionalHistologicHistopathologyHumanImageIn VitroIndividualMassachusettsMethodsMicroscopyMissionNeurodegenerative DisordersNeurofibrillary TanglesNeurologistNurses&apos Health StudyPathologyPerformancePhilosophyPlasmaProcessRNAReportingResearchResearch PersonnelResearch SupportResolutionRoleSamplingServicesStagingTissue BanksTissue DonationsTissue SampleTissuesTissues Repository OperationsTrainingUnited States National Institutes of HealthValidationWithdrawalWorkabstractingbasebrain tissuecareer developmentdata sharingdigitalend stage diseaseimaging modalityinnovationneuropathologynovelnovel strategiesoutreachpreventprogramstissue fixingtissue resourcetomographywhite matter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
NEUROPATHOLOGY CORE PROJECT SUMMARY/ABSTRACT
The underlying philosophy of the Neuropathology Core is the belief that validation of diagnosis is critical to
clinical research into neurodegenerative diseases and that tissue- and other biospecimen-based studies are a
vital complement to in vitro studies of the biologic processes underlying these diseases. From these two pillars
to the clinical and scientific community, the Core is able to make a contribution to the amelioration of suffering
associated with AD and related disorders. The Core therefore supports the overall mission of the MADRC
through the collection, characterization, storage and distribution of brain tissue and other biospecimens (CSF,
plasma, DNA, RNA, etc) from subjects who have been well-characterized clinically.
Samples from the Core have contributed to significant advances in our understanding of the biologic processes
that characterize neurodegenerative diseases, both at early and later stages.
The Core will serve to catalyze research into AD through collection, characterization and distribution of samples
to individual investigators, larger consortia and collaborative groups and through data sharing with NACC (Aims
1-4). There are components of the Core's activities which are innovative, focused on developing novel tissue
handling methods for high resolution microscopy which is important for understanding of early events in AD, on
developing novel methods for imaging sharing and analysis and on harnessing opportunities provided by large
epidemiologic studies to gather samples from control and early stage subjects (Aims 5-7). Finally, there is an
educational component of the Core: training neuropathologists to be expert in diagnosis of neurodegenerative
diseases and in the operations of tissue repositories in support of research; and teaching other health
professionals about the importance of autopsy and tissue donation for research (Aims 8 & 9). The Core is
integrated into all Center activities with active interactions with Administrative, Clinical and Outreach Cores
regarding autopsy permission and education, with the Data Core regarding data storage and communication
with NACC, and with the projects. Projects 2 and 3 both depend on neuropathological samples from the Core,
and our routine evaluation of brains includes attention to the white matter, which complements Project 1's
Connectome studies. We also support the local research community and national initiatives, with 309 requests
for materials over the past 4 years (including >3600 frozen tissue samples and >17,000 unstained section).
Thus, there is an ever-increasing role for the activities of the Core in contributing to research in AD and other
dementing illnesses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuropathology Core
-
批准号:10378617
-
项目类别:
-
资助金额:$40.41万
-
财政年份:2019
-
负责人:MATTHEW P FROSCH
-
依托单位:
Neuropathology Core
-
批准号:10620678
-
项目类别:
-
资助金额:$35.37万
-
财政年份:2019
-
负责人:MATTHEW P FROSCH
-
依托单位:
TRANSGENIC AND KNOCKOUT ANIMAL CORE
-
批准号:7483177
-
项目类别:
-
资助金额:$35.81万
-
财政年份:2007
-
负责人:MATTHEW P FROSCH
-
依托单位:
Spatial and temporal progression of amyloid angiopathy
-
批准号:6789393
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2002
-
负责人:MATTHEW P FROSCH
-
依托单位:
Spatial and temporal progression of amyloid angiopathy
-
批准号:6934575
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2002
-
负责人:MATTHEW P FROSCH
-
依托单位:
Spatial and Temporal Progression of Amyloid Angiopathy
-
批准号:7844849
-
项目类别:
-
资助金额:$41.8万
-
财政年份:2002
-
负责人:MATTHEW P FROSCH
-
依托单位:
Spatial and Temporal Progression of Amyloid Angiopathy
-
批准号:7477778
-
项目类别:
-
资助金额:$39.8万
-
财政年份:2002
-
负责人:MATTHEW P FROSCH
-
依托单位:
Spatial and Temporal Progression of Amyloid Angiopathy
-
批准号:7320383
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2002
-
负责人:MATTHEW P FROSCH
-
依托单位:
Spatial and Temporal Progression of Amyloid Angiopathy
-
批准号:7617178
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2002
-
负责人:MATTHEW P FROSCH
-
依托单位:
Core--Neuropathology of Parkinson's disease and related Lewy body disorders
-
批准号:6499889
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2001
-
负责人:MATTHEW P FROSCH
-
依托单位:
Core--Neuropathology of Parkinson's disease and related Lewy body disorders
-
批准号:6354788
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2000
-
负责人:MATTHEW P FROSCH
-
依托单位:
CORE--TRANSGENIC ANIMAL
-
批准号:6345909
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2000
-
负责人:MATTHEW P FROSCH
-
依托单位:
Core--Neuropathology of Parkinson's disease and related Lewy body disorders
-
批准号:6341055
-
项目类别:
-
资助金额:$29.46万
-
财政年份:2000
-
负责人:MATTHEW P FROSCH
-
依托单位:
CORE--TRANSGENIC ANIMAL
-
批准号:6201072
-
项目类别:
-
资助金额:$22.37万
-
财政年份:1999
-
负责人:MATTHEW P FROSCH
-
依托单位:
Core--Neuropathology of Parkinson's disease and related Lewy body disorders
-
批准号:6302895
-
项目类别:
-
资助金额:$29.46万
-
财政年份:1999
-
负责人:MATTHEW P FROSCH
-
依托单位:
Core--Neuropathology of Parkinson's disease and related Lewy body disorders
-
批准号:6259569
-
项目类别:
-
资助金额:$29.46万
-
财政年份:1999
-
负责人:MATTHEW P FROSCH
-
依托单位:
CORE--TRANSGENIC ANIMAL
-
批准号:6098805
-
项目类别:
-
资助金额:$22.37万
-
财政年份:1998
-
负责人:MATTHEW P FROSCH
-
依托单位:
Transgenic Animals
-
批准号:7468592
-
项目类别:
-
资助金额:$13.49万
-
财政年份:1998
-
负责人:MATTHEW P FROSCH
-
依托单位:
PRESENILIN 1 TRANSGENIC MICE--ALZHEIMER DISEASE MODELS
-
批准号:2408471
-
项目类别:
-
资助金额:$6.31万
-
财政年份:1997
-
负责人:MATTHEW P FROSCH
-
依托单位:
NOVEL ENDOTHELIAL CELL CADHERIN LIKE MOLECULE
-
批准号:2211258
-
项目类别:
-
资助金额:$8.69万
-
财政年份:1994
-
负责人:MATTHEW P FROSCH
-
依托单位:
海外基金